Kinaxis (TSE:KXS) Given a C$210.00 Price Target by Royal Bank Of Canada Analysts

Kinaxis (TSE:KXSGet Free Report) has been given a C$210.00 price objective by research analysts at Royal Bank Of Canada in a research note issued to investors on Wednesday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 21.63% from the company’s current price.

A number of other brokerages also recently issued reports on KXS. BMO Capital Markets upped their price target on Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Canadian Imperial Bank of Commerce upped their target price on shares of Kinaxis from C$173.00 to C$205.00 in a report on Friday, June 5th. National Bank Financial increased their target price on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Finally, Stifel Nicolaus cut their price target on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Seven investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of C$203.12.

Get Our Latest Stock Analysis on Kinaxis

Kinaxis Stock Down 1.6%

Shares of TSE:KXS traded down C$2.85 on Wednesday, hitting C$172.66. 68,620 shares of the company’s stock were exchanged, compared to its average volume of 120,421. The firm’s 50-day moving average is C$160.57 and its 200 day moving average is C$147.88. The company has a market capitalization of C$4.69 billion, a PE ratio of 56.42, a P/E/G ratio of 3.60 and a beta of 0.76. Kinaxis has a 1-year low of C$117.22 and a 1-year high of C$192.14. The company has a debt-to-equity ratio of 11.14, a quick ratio of 2.29 and a current ratio of 1.88.

Kinaxis (TSE:KXSGet Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$1.08 EPS for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%.The business had revenue of C$230.64 million for the quarter. Sell-side analysts predict that Kinaxis will post 4.2526231 EPS for the current year.

Insider Activity at Kinaxis

In other Kinaxis news, Director Gillian H. (Jill) Denham sold 15,968 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of C$171.36, for a total value of C$2,736,276.48. Following the completion of the sale, the director owned 18,732 shares in the company, valued at approximately C$3,209,915.52. The trade was a 46.02% decrease in their ownership of the stock. Also, insider Mark Justin Morgan sold 3,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of C$172.25, for a total value of C$516,750.00. Following the completion of the sale, the insider directly owned 10,299 shares of the company’s stock, valued at C$1,774,002.75. The trade was a 22.56% decrease in their ownership of the stock. Insiders have sold a total of 34,026 shares of company stock valued at $5,795,539 over the last 90 days. 1.20% of the stock is owned by insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Articles

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.